Advent Pharma Ltd. (DSE: ADVENT)
Bangladesh
· Delayed Price · Currency is BDT 17.20
+0.70 (4.24%)
At close: Nov 14, 2024
Advent Pharma Cash Flow Statement
Financials in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | Jun '19 Jun 30, 2019 | 2018 - 2016 |
| Net Income | 92.4 | 98.64 | 97.53 | 113.59 | 117.05 | 158.4 | Upgrade
|
| Depreciation & Amortization | 74.64 | 59.18 | 42.27 | 38.75 | 33.7 | 24.63 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.02 | - | 0.39 | - | 1.66 | Upgrade
|
| Other Operating Activities | 39.68 | 38.47 | 38.36 | 24.42 | 44.01 | 47.38 | Upgrade
|
| Change in Accounts Receivable | -4.34 | -10.32 | -2.15 | 4.21 | -39.39 | -26.83 | Upgrade
|
| Change in Inventory | 3.61 | 0.78 | -5.12 | -7.53 | 2.92 | -7.13 | Upgrade
|
| Change in Accounts Payable | 3.42 | 10.83 | 1.08 | -1.31 | 4.89 | 0.06 | Upgrade
|
| Change in Other Net Operating Assets | 8.86 | 7.7 | 7.6 | 7.86 | 6.91 | 6.38 | Upgrade
|
| Operating Cash Flow | 218.28 | 205.3 | 179.57 | 180.38 | 170.1 | 204.55 | Upgrade
|
| Operating Cash Flow Growth | 19.15% | 14.33% | -0.45% | 6.05% | -16.84% | 85.69% | Upgrade
|
| Capital Expenditures | -204.8 | -202.73 | -191.13 | -184.06 | -212.42 | -273.27 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.68 | - | 0.23 | - | 0.25 | Upgrade
|
| Investment in Securities | - | - | 40 | - | 40 | -65 | Upgrade
|
| Other Investing Activities | - | - | - | - | - | -0.08 | Upgrade
|
| Investing Cash Flow | -204.8 | -202.06 | -151.13 | -183.83 | -172.42 | -338.1 | Upgrade
|
| Short-Term Debt Issued | - | 11.72 | 6.44 | 13.47 | 16.12 | - | Upgrade
|
| Total Debt Issued | -0.05 | 11.72 | 6.44 | 13.47 | 16.12 | - | Upgrade
|
| Short-Term Debt Repaid | - | - | - | - | - | -12.95 | Upgrade
|
| Long-Term Debt Repaid | - | -4.04 | -4.2 | -2.59 | -3.23 | -4.34 | Upgrade
|
| Total Debt Repaid | -0.45 | -4.04 | -4.2 | -2.59 | -3.23 | -17.29 | Upgrade
|
| Net Debt Issued (Repaid) | -0.5 | 7.68 | 2.25 | 10.88 | 12.89 | -17.29 | Upgrade
|
| Common Dividends Paid | -8.58 | -8.81 | -22.22 | -8.08 | -8.71 | -5.47 | Upgrade
|
| Other Financing Activities | -4.98 | -5.35 | -6.84 | -3.01 | -4.25 | -6.35 | Upgrade
|
| Financing Cash Flow | -14.06 | -6.48 | -26.82 | -0.21 | -0.08 | -29.11 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | - | 0 | - | Upgrade
|
| Net Cash Flow | -0.58 | -3.24 | 1.63 | -3.65 | -2.4 | -162.65 | Upgrade
|
| Free Cash Flow | 13.48 | 2.56 | -11.56 | -3.67 | -42.33 | -68.71 | Upgrade
|
| Free Cash Flow Margin | 2.37% | 0.46% | -2.18% | -0.73% | -7.93% | -11.41% | Upgrade
|
| Free Cash Flow Per Share | 0.14 | 0.03 | -0.12 | -0.04 | -0.45 | -0.74 | Upgrade
|
| Cash Interest Paid | 4.98 | 5.35 | 6.83 | 3.01 | 4.23 | 6.05 | Upgrade
|
| Cash Income Tax Paid | 2.8 | 3.08 | 2.36 | 3.9 | 6.62 | 11.92 | Upgrade
|
| Levered Free Cash Flow | -28.98 | -44.03 | -68.27 | -56.36 | -103.46 | -122.14 | Upgrade
|
| Unlevered Free Cash Flow | -23.84 | -39.89 | -65.7 | -53.3 | -100.68 | -118.76 | Upgrade
|
| Change in Net Working Capital | -25.61 | -19.06 | 0.21 | -6.74 | 19.09 | 2.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.